Datatrak International said it has been offered a minimum of $3m
(€2.4m) worth of contracts for next year out of a deal struck with
its first "multibillion-dollar" pharma firm in the second quarter.
Agilent Technologies has chosen Distek to be its number-one
provider for dissolution instrumentation service in North America
under its Lab Resource Management (LRM) programme.
Prosonix has launched a new particle engineering technology in an
attempt to reach the inhaled drug delivery market - at the same
time the British firm has extended an agreement with UCB for the
use of its existing sonocrystallisation...
UK pharmaceutical companies are not doing enough to attract fresh
talent to the industry and face serious future recruitment issues
if they don't get their act together now, warns a new report.
The US Food and Drug Administration (FDA) has admitted that more
needs to be done to ensure the safe and effective use of
prescription drugs, after a report urged the regulator to revamp
its drug safety system.
The US Food and Drug Administration (FDA) has come under scrutiny
after an independent report urged the regulator to implement large
reforms to ensure the safety of new prescription drugs.
Responding to Roche's licensing agreements for Tamiflu (oseltamivir
phosphate) around the world, GlaxoSmithKline (GSK) has granted
China's Simcere Pharmaceutical Group the right to make generic
copies of its influenza drug...
The European Commission continues to be accused by European
industry of pushing 'green policies' that are stifling progress and
global competitiveness - the controversial REACH chemicals
legislation remains a sore point.
Dr. Reddy's Laboratories has announced the inauguration of its
seventh finished dosage plant in India, reflecting the country's
unprecedented growth as a generic pharmaceuticals manufacturer.
With sales of its vaccines expected to triple in the next ten
years, GlaxoSmithKline (GSK) has decided to invest more than €500m
in a new manufacturing facility in St-Amand-Les-Eaux in order to
increase production capacity for paediatric...
The founder of start-up pharmaceutical company has been charged in
a US federal court with assuming the identity of an employee of
Nabi Biopharmaceuticals in order to obtain information useful in
the generic production of a kidney...
US contract pharmaceutical manufacturer Metrics has announced a
$17.5m (€13.7m) investment to double the size of its drug testing
and manufacturing plant over the next three years.
UK research organisations, biopharmaceutical and food
manufacturers, along with those in other industries are been asked
to voluntarily provide any information on nanotechnologies they are
working on, under a programme launched this...
Under pressure to respond to the spread of HIV in the developing
world, Gilead has signed non-exclusive licence agreements with
eight Indian generic companies for the manufacture of Viread
(tenofovir disoproxil fumarate), its popular...
Drug makers need to put in place greater cold chain management
capacity, in house or by outsourcing the service, as the biotech
market continues to boom.
To escape stagnating growth, hospital supplies firm Hospira has
agreed to buy Australia's Mayne Pharma for $2bn (€1.56bn), creating
the world's biggest manufacturer of generic injectable drugs.
Most drug companies are not planning to increase the level of sales
and marketing IT they outsource over the next 3-5 years - a sign
that this niche segment may be bucking the wider pharmaceutical
industry outsourcing trend.
MedImmune has embarked on an expansion of its biologics
manufacturing facility in Frederick, Maryland, to ramp up its cell
culture production capacity, as several of its monoclonal
antibodies (MAbs) approach commercialisation.
A warning letter from the US Food and Drug Administration (FDA)
censuring Actavis for failing to file periodic safety reports at
its solid oral dose manufacturing facility in New Jersey and not
reporting adverse drug events has forced...
Roche has boosted annual manufacturing capacity for Tamiflu
(oseltamivir phosphate) to 80m treatment courses, as demand for the
flu drug shows no sign of abating.
The European Union (EU) has been criticised for being more
favourable to big biotech companies, at the expense of smaller
firms, according to consultants within the industry.
Pfizer's manufacturing reforms have claimed more casualties in two
North American plants as the world's largest drugmaker battles to
realign production capacity with future product mix, new
technologies and cost effectiveness.
A good selection process, with a realistic set of selection
criteria is essential when looking for the right contract
manufacturing partner, according to a new Datamonitor report.
Offshoring contract manufacturing is not the only option for large
pharma firms looking to drive productivity and efficiency gains in
drug manufacturing, warns a new report from independent market
analyst Datamonitor.
Workers at a Rhodia specialty chemicals plant in South Carolina are
sighing with relief after a fire that broke out in the passing of
tropical storm Ernesto was put out before igniting ethanol and
pentane in a general processing unit.
As the bio-outsourcing market hits boom time, the number of
contract biomanufacturing organisations (CBMOs) that specialise in
the production of biopharma products, is rapidly expanding.
Capgemini has received a new five year outsourcing contract to
provide IT services to ensure the smooth sailing of pharmaceutical
company Astellas US, newly-formed after a recent merger.
GlaxoSmithKline (GSK), a major player in vaccine manufacturing, is
set to inaugurate a €100m vaccine production plant on Friday in a
Hungarian city 30Km northeast of Budapest.
Chemokine Therapeutics has announced it has received a patent
relating to chemokine analogs for the treatment of human disease,
which includes autoimmune diseases, cancer, cardiovascular disease,
and inflammatory disorders such as...
Portuguese drug producers are small and need to merge or form
alliances to compete at a global level, investing more in
innovation and increasing their competitiveness like custom
manufacturer Hovione has done, a new report by market...
The market for radiofrequency identification (RFID) tags in
healthcare is set to explode from $90m (€70m) in 2006 to $2.1bn in
2016, driven by the item level tagging of drugs and the growing
appeal of "smart packaging."
TNS Healthcare has scooped up a new deal with Pfizer to provide the
drug giant's UK arm with sales and market information in order to
help them achieve their sales objectives.
The battle for the acquisition that will form the world's third
biggest generic drugmaker has intensified, with Iceland's Actavis
making a new offer for Croatian drug manufacturer Pliva that
surpasses that of US pharmaceutical...
Bruised by Novartis's snub over a $600m (€466m) vaccine plant,
Maryland has commissioned a study on what more the state can do to
attract a major cell culture vaccine manufacturing facility there.
US generic drugmaker Mylan has agreed to spend around $736m
(€573.4m) to acquire a controlling stake in Matrix, an Indian
manufacturer of active pharmaceutical ingredients (APIs) and solid
oral dosage forms, as relentless competition...
Jacobs Engineering Group has inked a new contract with Boehringer
Ingelheim to provide technical and construction services for its
new bulk active pharmaceutical ingredient (API) facility being
built in Petersburg, Virginia, US.
Looking for $45m (€35m) in savings, Teva has decided to abandon its
drug manufacturing plant in Cidra, Puerto Rico, as it scrambles to
adjust capacity seven months after its acquisition of Ivax.
Sentry Logistic Solutions has launched an additional service,
offering to build customised drug storage facilities for
pharmaceutical companies with special needs.
As it continues to expand, Decision News Media is currently seeking
two new journalists to join its Pharmaceutical & Science News
Group in Central London.
Spurred on by the frustration of drug manufacturers, governors from
four US states have petitioned the US Food and Drug Administration
(FDA) for clarity in their requirements for the production of
generic versions of insulin and human...
The convenience of non-invasive insulin delivery methods is set to
overcome their high cost and concerns about safety and efficacy,
with the greatest beneficiary being the European inhaled insulin
market which is predicted to swell...
India's potential to further boost its already dominant role in
global generics production, as well as an offshore location of
choice for contract manufacturing, presents an opportunity worth an
estimated $48bn (€38bn) in 2007,...
Gentronix has been granted a research award, which is to fund a
potentially viable alternative to animal testing, reducing the need
for their use during drug development.
Pharmaceutical manufacturers will be among a number of exporters
and importers operating within the EU that face paying tens of
millions of euros to comply with a new regulation aimed at reducing
terrorism, fraud and counterfeit products.
Europe's third party logistics providers (3PL) are evolving to
integrate more of their operations with those of their clients in a
bid to provide a more efficient service, leaving the old breed in
danger of becoming extinct.
Are big pharma companies uninterested in supporting novel
formulations, preferring to stick to low-risk drug delivery
systems, or are they resourceful innovators that bring new
technologies to the market? Two pharma grandees holding...
More and more drugmakers are turning to health care companies not
just for their drug delivery technologies but also for their
regulatory and manufacturing expertise, asking them to take their
product from early stages all the way...
The Food and Drug Administration (FDA) will beef up its process for
disclosing the conflicts of interest of its advisory experts in a
bid to restore its reputation after a survey suggests its
scientists may be too closely tied with...